StoxPrivi Speciality Chemicals vs Jubilant Ingrevia: share price & financials comparison
NSE: PRIVISCL vs JUBLINGREA · Chemicals · as of 06 Nov 2026
Both prices rebased to 100 at the start of the selected period.
Privi Speciality Chemicals vs Jubilant Ingrevia at a glance
Privi Speciality Chemicals (PRIVISCL) has a market capitalisation of ₹13,145 Cr, against ₹9,022 Cr for Jubilant Ingrevia (JUBLINGREA). Over the past year Privi Speciality Chemicals has returned +17.8%, compared with -16.9% for Jubilant Ingrevia. On valuation, Jubilant Ingrevia trades at a lower P/E of 25.7 versus 47.1. Privi Speciality Chemicals earns a higher return on equity (17.7% vs 10.6%). Privi Speciality Chemicals comes out ahead on profitability, momentum and technicals. Jubilant Ingrevia comes out ahead on size, valuation, growth and financial health. Across the scored metrics below, Privi Speciality Chemicals leads on 9 and Jubilant Ingrevia on 7. On StoxGud's 10-point checklist, Privi Speciality Chemicals scores 8/10 and Jubilant Ingrevia scores 3/10.
| Metric | Privi Speciality Chemicals | Jubilant Ingrevia |
|---|---|---|
| Size | ||
| Market cap | ₹13,145 Cr | ₹9,022 Cr |
| Revenue (latest FY) | ₹2,564 Cr | ₹4,388 Cr |
| Net profit (latest FY) | ₹0 Cr | ₹278 Cr |
| Valuation | ||
| P/E | 47.1 | 25.7 |
| P/B | 8.35 | 2.72 |
| Dividend yield | 0.15% | 0.88% |
| Profitability | ||
| Return on equity | 17.7% | 10.6% |
| Net profit margin | 10.1% | 7.1% |
| Operating margin | 24.8% | 14.2% |
| Growth | ||
| Revenue growth (YoY) | +12.0% | +24.4% |
| Net profit growth (YoY) | — | +60.4% |
| Revenue CAGR (multi-year) | +15.0% | +45.0% |
| Financial health | ||
| Debt to equity | 0.62 | 0.27 |
| Momentum | ||
| 1-month return | -4.4% | -10.9% |
| 1-year return | +17.8% | -16.9% |
| 3-year CAGR | +37.8% | +11.0% |
| 5-year CAGR | +14.2% | -3.1% |
| 10-year CAGR | +20.8% | — |
| Distance from 52W high | -10.3% | -25.1% |
| Technicals | ||
| RSI (14) | 51 | 36 |
| Price vs 200-day avg | +3.0% | -12.9% |
Highlighted cells lead on that metric. Market cap, revenue and RSI are shown for context and not scored.
10-point checklist side by side
| Check | Privi Speciality Chemicals | Jubilant Ingrevia |
|---|---|---|
| Price above 50-day average | ✗ | ✗ |
| Price above 200-day average | ✓ | ✗ |
| 50-day average above 200-day (uptrend) | ✓ | ✗ |
| RSI in healthy 40–70 zone | ✓ | ✗ |
| Positive 1-year return | ✓ | ✗ |
| Return on equity above 15% | ✓ | ✗ |
| Debt to equity below 1 | ✓ | ✓ |
| Revenue growing year on year | ✓ | ✓ |
| Net profit margin above 10% | ✓ | ✗ |
| P/E below industry median | ✗ | ✓ |
| Score | 8/10 | 3/10 |
A rules-based screen for education only — not a buy or sell recommendation.
FAQs
Which is bigger, Privi Speciality Chemicals or Jubilant Ingrevia?
Privi Speciality Chemicals has a market cap of ₹13,145 Cr and Jubilant Ingrevia has a market cap of ₹9,022 Cr as of 06 Nov 2026.
Which has a lower P/E, Privi Speciality Chemicals or Jubilant Ingrevia?
Jubilant Ingrevia has the lower P/E: Privi Speciality Chemicals trades at 47.1 and Jubilant Ingrevia at 25.7.
Which gave better returns in the last year, Privi Speciality Chemicals or Jubilant Ingrevia?
Privi Speciality Chemicals did better: Privi Speciality Chemicals returned +17.8% and Jubilant Ingrevia returned -16.9% over one year.
Is Privi Speciality Chemicals or Jubilant Ingrevia a better buy?
StoxGud does not give buy or sell recommendations. On our rules-based checklist Privi Speciality Chemicals scores 8/10 and Jubilant Ingrevia scores 3/10; compare valuation, profitability, growth and momentum above and consult a SEBI-registered adviser.